CAMBRIDGE, Mass, October 2, 2023 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the following investor conferences: Chardan’s 7th Annual Genetic Medicines Conference, taking place October 2-3, 2023, in NY Oppenheimer’s Private Company Symposium, taking place October 11, 2023, in NY 3rd Annual Needham Private Biotech […]

CAMBRIDGE, Mass., Aug. 31, 2023 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the following investor conferences: Citi’s 18th Annual BioPharma Conference, taking place September 5-7, 2023, in Boston, MA Management will participate in a fireside chat on September 6, 2023, at 11:20 am ET. […]

CAMBRIDGE, Mass, May 22, 2023 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company, today announced that it will participate in the SVB Securities Biopharma Company Connect event, taking place virtually May 24th- 25th, 2023. Myeloid management will participate in virtual one-on-one meetings with investors during the event. About Myeloid Therapeutics Myeloid Therapeutics is […]